Dynamics of drug response informs rational combination regimens.

Paudel BB, Quaranta V
Sci Signal. 2019 12 (595)

PMID: 31431544 · DOI:10.1126/scisignal.aax9742

Metabolic plasticity in cancer has been linked to the development of drug-tolerant populations. In this issue of , Goldman integrate metabolic plasticity with phenotypic state transitions to examine how this reprogramming can be therapeutically exploited.

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

MeSH Terms (5)

Adaptation, Physiological Drug Tolerance Humans Neoplasms Signal Transduction

Connections (2)

This publication is referenced by other Labnodes entities: